Rahul Banerjee
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Rahul Banerjee
Sep 20, 2024, 14:07 |
Blog
Rahul Banerjee: Congrats to Malin and the whole MSK team for this publication
Rahul Banerjee shared a post by Malin Hultcrantz, Associate Attending Physician, Assistant Professor at MSK…
Sep 12, 2024, 10:09 |
Blog
Experts in multiple myeloma weigh the benefits and risks of second malignancies following CAR-T in Multiple Myeloma - Cancer Network
Rahul Banerjee shared a post by Cancer Network on X, adding: "Thanks Cancer Network, The American Society for Transplantation and…
Sep 9, 2024, 09:26 |
Blog
Rahul Banerjee: AURIGA results in IMS 2024 app
Rahul Banerjee shared a post on X: ''AURIGA results in the International Myeloma Society (IMS)…
Sep 1, 2024, 08:24 |
Insight
Rahul Banerjee: Chronicle disparities in Relapsed or Refractory myeloma and why they matter
Rahul Banerjee shared on X: "Now in Blood Cancer Journal - our work to chronicle…
Aug 31, 2024, 16:59 |
Blog
Rahul Banerjee: Supporting parents at ASH24
Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X: "Such a…
Aug 25, 2024, 09:29 |
Insight
Rahul Banerjee: Fascinating Multiple Myeloma results of MajesTEC-1 in BCMA-exposed patients
Rahul Banerjee shared a post by Robert Z. Orlowski, Director of Myeloma Section at MD Anderson…
Aug 20, 2024, 14:29 |
Blog
Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?
Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…
Aug 14, 2024, 10:29 |
Insight
Rahul Banerjee: They say not all MRD negativity in myeloma is created equal
Rahul Banerjee shared on X: "They say not all MRD negativity in myeloma is created…
Aug 12, 2024, 22:03 |
Blog
Rahul Banerjee: Timothy Schmid about whole-body MRI imaging in multiple myeloma at DAVA Heme
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "DAVA Heme and now Timothy…
Aug 10, 2024, 13:10 |
Blog
Rahul Banerjee: DAVAHeme Bermuda 2024
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: "DAVAHeme Bermuda 2024.…
Aug 10, 2024, 12:42 |
Blog
Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva
Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X: "EXCELLENT Blood…
Aug 7, 2024, 01:13 |
Insight
Rahul Banerjee's perspectives on approval of daratumumab and hyaluronidase plus VRd in MM
Oncology Data Advisor shared on X: "Did you hear about last week's approval of daratumumab…
Aug 4, 2024, 03:36 |
Insight
Rahul Banerjee: Fascinating paper about time of day affecting CAR T-cell function
Rahul Banerjee, EASE (ECE Advocacy for Student Engagement) Director of Communications at Duke University Pratt…
Aug 2, 2024, 12:09 |
Societies
Rahul Banerjee: ASH24 advice for everyone going through the ASH dash
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "ASH24 advice for everyone going through the…
Aug 1, 2024, 08:32 |
Insight
Rahul Banerjee: A 'CAR-E' - basically a care package for CAR T-cells as they start their first jobs
Rahul Banerjee, Assistant Professor at UW Medicine, shared a posts by Mohammad Rashidian, Assistant Professor, Dana-Farber Cancer Institute,…
Aug 1, 2024, 04:52 |
Blog
Rahul Banerjee: Pleasure to be interviewed with Betsy O'Donnell about patient support group
Rahul Banerjee, Graduate Research Assistant at Duke University Pratt School of Engineering, shared CURE Today's…
Jul 29, 2024, 23:24 |
Blog
Murali Janakiram: Rahul Banerjee nearly convinced me to wait for CAR T
Murali Janakiram, Associate Professor of Division of Hematological Malignancies at City of Hope, shared a…
Jul 29, 2024, 21:02 |
Blog
GDUHEM summarized by Rahul Banerjee
GDUHEM (The Great Debates and Updates in Hematologic Malignancies) event took place in Los Angeles…
Jul 28, 2024, 15:35 |
Insight
IgG replacement in myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, shared a paper by Rafael Fonseca et al on…
Jul 28, 2024, 13:30 |
Blog
Rahul Banerjee: Looking forward to GDUHEM this weekend
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: "Looking forward to discussing…
Jul 28, 2024, 12:28 |
Insight
Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…
Jul 28, 2024, 08:13 |
Blog
Rahul Banerjee: How different BCMA Treatment fare in Multiple myeloma by Matthew J Rees, Vincent Rajkumar et al
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "Great Blood Cancer work by Matthew…
Jul 28, 2024, 07:55 |
Blog
Luciano J Costa: MRD accelerating myeloma drug development
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Luciano J Costa, Professor of…
Jul 26, 2024, 00:11 |
Blog
Rahul Banerjee's perspectives on the future of AI in oncology - Oncology Data Advisor
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Oncology Data Advisor on X,…
Jul 20, 2024, 21:30 |
Insight
Rahul Banerjee: ARROW2 was here all this time and just got published in Blood Advances
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by, Robert Z. Orlowski, on X, adding:…
Jul 15, 2024, 21:23 |
Blog
Rahul Banerjee: From PI to BYE, it is time to say goodbye to myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "At the HealthTree Foundation myeloma…
Jul 14, 2024, 22:08 |
Blog
Rahul Banerjee: IL-18: magnifying glass, rejuvenating cream, and phone-a-friend all in one for T cells
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: ''Fascinating MMsm work…
Jul 11, 2024, 14:47 |
Insight
Flow cytometry to predict when to offer boosters to patients with multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Bruno Paiva, Director Flow…
Jul 10, 2024, 00:26 |
Blog
Myeloma podcast on BCMA-targeting bispeciifc antibodies - VJHemOnc
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) shared on X: "Did you know…
Jul 9, 2024, 06:35 |
Blog
Rahul Banerjee: Nice analysis of Australia/New Zealand multiple myeloma with emphasis on CRAB vs SLiM
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Now in The…
Jul 7, 2024, 14:46 |
Opinion
Rahul Banerjee: Fascinating 3-way randomized trial of neuromuscular training
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “This is…
Jul 3, 2024, 02:35 |
Insight
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Absolutely abscopal…
Jun 21, 2024, 08:50 |
Blog
Rahul Banerjee: All I care about in myeloma is VGPR report
Rahul Banerjee, Assistant Professor at UW Medicine, shared Rafael Fonseca's post on X, adding: …
Jun 13, 2024, 06:08 |
Blog
Rahul Banerjee: So honored to have gotten Shaji Kumar’s wisdom on so many multiple myeloma questions
Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared on X: "So honored to…
Jun 11, 2024, 11:27 |
Blog
Rahul Banerjee: Excellent multiple myeloma work in Blood Cancer Journal
Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared a post by Mattia D'Agostin,…
May 27, 2024, 04:03 |
Opinion
Rahul Banerjee: My top 10 ASCO 24 multiple myeloma abstracts
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
May 21, 2024, 15:48 |
Blog
Cancer Network - A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X: "So much fun…
May 21, 2024, 13:21 |
Insight
Rahul Banerjee: Two-for-one with new MMsm articles in press in Transplantation and Cellular Therapy Journal
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
May 17, 2024, 13:44 |
Drugs
Rahul Banerjee: Analysis of carfilzomib dosing in R/R myeloma
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, posted…
Apr 28, 2024, 13:30 |
Blog
Rahul Banerjee: Now in CLML - The Netherlands study of myeloma MMsm income pre- and post-diagnosis
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, posted…
Feb 14, 2024, 19:34 |
Blog
Robin Tuohy: We look forward to seeing our myeloma friends in the San Diego area at International IMF Regional Community Workshop!
Robin Tuohy, Vice-President of Support Groups at the International Myeloma Foundation, shared International Myeloma Foundation's…
Dec 17, 2023, 17:14 |
Insight
Ajay Major: Critically important multiple myeloma study from ASH23
Quoting Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder…
Aug 13, 2023, 10:01 |
Blog
,
Drugs
Rahul Banerjee: How do we standardize the standard of care for bortezomib (Velcade) in multiple myeloma?
Rahul Banarjee, Assistant Professor in the Division of Medical Oncology at the University of Washington,…
All:
43
Posts:
1 - 100
OncoDaily Forms Strategic Partnership with the National Foundation for Cancer Research (NFCR)
Hugh Jackman and Skin Cancer: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 4
34 Posts Not to Miss From ESMO24 Day 4
40 Posts Not To Miss From ESMO24 Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube